Skip to content
PharmaInsight

Powder extensively hydrolysed formula (0913101) vs Pdr disc/non ACBS protein SfI metabolic condition (0913442)

National NHS prescribing compared (Prescription Cost Analysis)
Data updated March 2026

Powder extensively hydrolysed formula (0913101) was dispensed 41,759.0× as often as Pdr disc/non ACBS protein SfI metabolic condition (0913442) in March 2026 — 41,759 items versus 1 in England.

41,759items

Powder extensively hydrolysed formula (0913101) · March 2026

NHSBSA Prescription Cost Analysis

1items

Pdr disc/non ACBS protein SfI metabolic condition (0913442) · March 2026

NHSBSA Prescription Cost Analysis

Figure 1. Powder extensively hydrolysed formula (0913101) versus Pdr disc/non ACBS protein SfI metabolic condition (0913442): national items dispensed by month

▬ Powder extensively hydrolysed formula (0913101)   ·   ╌ Pdr disc/non ACBS protein SfI metabolic condition (0913442)

Pdr disc/non ACB… 41,759

Source: NHSBSA Prescription Cost Analysis, to March 2026

Powder extensively hydrolysed formula (0913101) versus Pdr disc/non ACBS protein SfI metabolic condition (0913442), March 2026
Measure Powder extensively hydrolysed formula (0913101) Pdr disc/non ACBS protein SfI metabolic condition (0913442)
Items, March 2026 41,759 1
Items, last 12 months 490,419 17
Net ingredient cost, March 2026 £3,118,227 £604

See the full profile for Powder extensively hydrolysed formula (0913101) or Pdr disc/non ACBS protein SfI metabolic condition (0913442).